参考文献/References:
[1] LI Q,DU X,ZHANG Y,et al.The prevalence,risk factors and clinical correlates of obesity in Chinese patients with schizophrenia[J].Psychiatry Res,2017,251:131-136.
[2] RIETSCHEL L,LAMBERT M,KAROW A,et al.Clinical high risk for psychosis:gender differences in symptoms and social functioning[J].Early Interv Psychiatry,2017,11(4):306-313.
[3] GOLDSTEIN J M,CHERKERZIAN S,TSUANG M T,et al.Sex differences in the genetic risk for schizophrenia:history of the evidence for sex-specific and sex-dependent effects[J].Am J Med Genet B Neuropsychiatr Genet,2013,162B(7):698-710.
[4] HUANG Y C,HUNG C F,LIN P Y,et al.Gender differences in susceptibility to schizophrenia:potential implication of neurosteroids[J].Psychoneuroendocrinology,2017,84:87-93.
[5] 杜云红,吕惠娟.二甲双胍联合行为干预对奥氮平所致精神分裂症患者体质量增加及糖脂代谢紊乱的影响[J].新乡医学院学报,2014,31(5):381-384.
[6] LI Q,CHEN D,LIU T,et al.Sex differences in body mass index and obesity in Chinese patients with chronic schizophrenia[J].J Clin Psychopharmacol,2016,36(6):643-648.
[7] OCHOA S,USALL J,COBO J,et al.Gender differences in schizophrenia and first-episode psychosis:a comprehensive literature review[J].Schizophr Res Treatment,2012,2012:916198.
[8] GARDNER D M,MURPHY A L,O′DONNELL H,et al.International consensus study of antipsychotic dosing[J].Am J Psychiatry,2010,167(6):686-693.
[9] ABORAYA A,NASRALLAH H A.Perspectives on the positive and negative syndrome scale (PANSS):use,misuse,drawbacks,and a new alternative for schizophrenia research[J].Ann Clin Psychiatry,2016,28(2):125-131.
[10] WALLWORK R S,FORTGANG R,HASHIMOTO R,et al.Searching for a consensus five-factor model of the Positive and Negative Syndrome Scale for schizophrenia[J].Schizophr Res,2012,137(1/2/3):246-250.
[11] JI C Y,CHEN T J.Empirical changes in the prevalence of overweight and obesity among Chinese students from 1985 to 2010 and corresponding preventive strategies[J].Biomed Environ Sci,2013,26(1):1-12.
[12] 刘旭恩,沈姣,张美霞.阿立哌唑联合无抽搐电休克治疗女性难治性精神分裂症疗效观察[J].新乡医学院学报,2017,34(9):847-850.
[13] 黄飞,姜祥智.青岛地区非自愿住院精神分裂症病人临床特征的性别差异[J].齐鲁医学杂志,2017,32(3):331-333.
[14] 张杰,薛士健,周燕玲,等.精神分裂症患者临床特征的性别差异[J].四川精神卫生,2015,28(4):299-302.
[15] 胡春水,李君,田源,等.长期住院对慢性精神分裂症患者认知功能的影响[J].中国医药导报,2017,14(8):60-63.
[16] LAM B Y,RAINE A,LEE T M.The relationship between neurocognition and symptomatology in people with schizophrenia:social cognition as the mediator[J].BMC Psychiatry,2014,14:138-147.
[17] ZHANG X Y,LIANG J,CHEN D C,et al.Cigarette smoking in male patients with chronic schizophrenia in a Chinese population:prevalence and relationship to clinical phenotypes[J].PLoS One,2012,7(2):e30937.
[18] DAVIS S R,CASTELO-BRANCO C,CHEDRAUI P,et al.Understanding weight gain at menopause[J].Climacteric,2012,15(5):419-429.
[19] XU Y,WANG F.Built environment and obesity by urbanicity in the U.S[J].Health Place,2015,34:19-29.
[20] 徐海冬,桑艳梅,闫洁,等.脂肪含量和肥胖相关基因与中国儿童肥胖病遗传发病机制的相关性[J].中华实用儿科临床杂志,2013,28(20):1544-1547.
相似文献/References:
[1]黄远学,王长虹,苏秀芝,等.77例出院后精神分裂症患者心理调查分析[J].新乡医学院学报,1994,11(03):227.
[2]娄百玉,石玉中,韩巍巍,等.未婚女精神分裂症患者父母的心理分析 [J].新乡医学院学报,1994,11(04):375.
[3]郭素芹,吕路线,郭云,等.一次量氯氮平对精神分裂症患者脑电活动的影响[J].新乡医学院学报,1997,14(02):122.
[4]宋晓敏 杨 冰 杜 玮 郭长磊 李根旺 邬玉芳 郭丽萍.豆番粉与玉米粉对人体血糖胰岛素胰升血糖素的影响[J].新乡医学院学报,1998,15(03):234.
[5]查彩慧 郭国庆.氯丙嗪氯氮平合用治疗精神分裂症临床疗效评价[J].新乡医学院学报,1999,16(04):311.
[6]郭慧荣,张绍荣. 孙富根.利培酮与氯氮平治疗精神分裂症的临床对照研究[J].新乡医学院学报,2001,18(03):174.
[7]李彩霞,张钰,何艳.冬季和夏季出生的精神分裂患者的临床差异[J].新乡医学院学报,2001,18(05):348.
[8]杜云红,郝以辉,王新友.儿童期精神分裂症预后的影响因素分析[J].新乡医学院学报,2001,18(01):058.
[9]扬世昌,祁富生,张疆丽.利培酮治疗精神分裂症2O例[J].新乡医学院学报,2002,19(02):113.
[10]王长虹,李 晏,贾福军,等.工、Ⅱ型精神分裂症患者血清免疫指标的对照分析[J].新乡医学院学报,2002,19(05):360.